227 related articles for article (PubMed ID: 27987584)
1. Corneal graft rejection in a patient treated with nivolumab for primary lung cancer.
Le Fournis S; Gohier P; Urban T; Jeanfaivre T; Hureaux J
Lung Cancer; 2016 Dec; 102():28-29. PubMed ID: 27987584
[TBL] [Abstract][Full Text] [Related]
2. Use of the PD-1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy.
Boils CL; Aljadir DN; Cantafio AW
Am J Transplant; 2016 Aug; 16(8):2496-7. PubMed ID: 26988410
[No Abstract] [Full Text] [Related]
3. Resolution of Infliximab-Refractory Nivolumab-Induced Acute Severe Enterocolitis After Cyclosporine Treatment in a Patient with Non-Small Cell Lung Cancer.
Iyoda T; Kurita N; Takada A; Watanabe H; Ando M
Am J Case Rep; 2018 Mar; 19():360-364. PubMed ID: 29581417
[TBL] [Abstract][Full Text] [Related]
4. Nivolumab: a review in advanced squamous non-small cell lung cancer.
Keating GM
Drugs; 2015 Nov; 75(16):1925-34. PubMed ID: 26514815
[TBL] [Abstract][Full Text] [Related]
5. [Psoriasis and Psoriatic Arthritis Induced by Nivolumab in a Patient with Advanced Non-Small-Cell Lung Cancer].
Sugiura Y; Fujimoto H; Yamamoto M; Nomura H; Hashizume T; Kawai O; Araki N; Kawakami K; Sueki H; Fusegawa H; Ohkubo Y; Nemoto E
Gan To Kagaku Ryoho; 2017 Sep; 44(9):787-789. PubMed ID: 28912410
[TBL] [Abstract][Full Text] [Related]
6. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Brahmer J; Reckamp KL; Baas P; Crinò L; Eberhardt WE; Poddubskaya E; Antonia S; Pluzanski A; Vokes EE; Holgado E; Waterhouse D; Ready N; Gainor J; Arén Frontera O; Havel L; Steins M; Garassino MC; Aerts JG; Domine M; Paz-Ares L; Reck M; Baudelet C; Harbison CT; Lestini B; Spigel DR
N Engl J Med; 2015 Jul; 373(2):123-35. PubMed ID: 26028407
[TBL] [Abstract][Full Text] [Related]
7. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.
Rizvi NA; Mazières J; Planchard D; Stinchcombe TE; Dy GK; Antonia SJ; Horn L; Lena H; Minenza E; Mennecier B; Otterson GA; Campos LT; Gandara DR; Levy BP; Nair SG; Zalcman G; Wolf J; Souquet PJ; Baldini E; Cappuzzo F; Chouaid C; Dowlati A; Sanborn R; Lopez-Chavez A; Grohe C; Huber RM; Harbison CT; Baudelet C; Lestini BJ; Ramalingam SS
Lancet Oncol; 2015 Mar; 16(3):257-65. PubMed ID: 25704439
[TBL] [Abstract][Full Text] [Related]
8. Presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis.
Jhanji V; Agarwal T; Sharma N; Vajpayee RB
Eye Contact Lens; 2010 Nov; 36(6):371-3. PubMed ID: 20935566
[TBL] [Abstract][Full Text] [Related]
9. Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer.
Kawakami H; Tanizaki J; Tanaka K; Haratani K; Hayashi H; Takeda M; Kamata K; Takenaka M; Kimura M; Chikugo T; Sato T; Kudo M; Ito A; Nakagawa K
Invest New Drugs; 2017 Aug; 35(4):529-536. PubMed ID: 28317087
[TBL] [Abstract][Full Text] [Related]
10. Risk of tumor flare after nivolumab treatment in patients with irradiated field recurrence.
Yoshida T; Furuta H; Hida T
Med Oncol; 2017 Mar; 34(3):34. PubMed ID: 28138869
[TBL] [Abstract][Full Text] [Related]
11. A Case Report of Steroid Responsive Nivolumab-Induced Encephalitis.
Richard K; Weslow J; Porcella SL; Nanjappa S
Cancer Control; 2017; 24(5):1073274817729069. PubMed ID: 28975824
[TBL] [Abstract][Full Text] [Related]
12. Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report.
Pluchart H; Pinsolle J; Cohen J; Ferretti GR; Bedouch P; Giaj Levra M; Toffart AC; Moro-Sibilot D
J Med Case Rep; 2017 Jul; 11(1):183. PubMed ID: 28679408
[TBL] [Abstract][Full Text] [Related]
13. Severe acute interstitial lung disease after nivolumab in three non-small cell lung cancer patients with imaging findings of airway obstruction adjacent to lung tumors.
Nakahama K; Tamiya A; Taniguchi Y; Sasaki Y; Akira M; Atagi S
J Infect Chemother; 2017 Dec; 23(12):826-829. PubMed ID: 28818548
[TBL] [Abstract][Full Text] [Related]
14. Case-control study of subconjunctival triamcinolone acetonide injection vs intravenous methylprednisolone pulse in the treatment of endothelial corneal allograft rejection.
Costa DC; de Castro RS; Kara-Jose N
Eye (Lond); 2009 Mar; 23(3):708-14. PubMed ID: 18820657
[TBL] [Abstract][Full Text] [Related]
15. Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection.
Hudde T; Minassian DC; Larkin DF
Br J Ophthalmol; 1999 Dec; 83(12):1348-52. PubMed ID: 10574812
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer.
Tanvetyanon T; Creelan BC; Antonia SJ
Expert Rev Anticancer Ther; 2016 Sep; 16(9):903-10. PubMed ID: 27488231
[TBL] [Abstract][Full Text] [Related]
17. Case series of pleomorphic carcinomas of the lung treated with nivolumab.
Kanazu M; Uenami T; Yano Y; Nakatsubo S; Hosono Y; Ishijima M; Akazawa Y; Yamaguchi T; Urasaki K; Mori M; Yokota S
Thorac Cancer; 2017 Nov; 8(6):724-728. PubMed ID: 28881488
[TBL] [Abstract][Full Text] [Related]
18. Late-occurring nivolumab-induced cryptogenic organising pneumonia mimicking lung progression in a patient with metastatic non-small cell lung cancer.
Mahjoubi L; Gazzah A; Marabelle A; Le Roy Ladurie F; Lambotte O; Caramella C; Adam J; Besse B; Soria JC
Eur J Cancer; 2017 Nov; 85():155-157. PubMed ID: 28917814
[No Abstract] [Full Text] [Related]
19. Intravenous dexamethasone vs methylprednisolone pulse therapy in the treatment of acute endothelial graft rejection.
Tandon R; Verma K; Chawla B; Sharma N; Titiyal JS; Kalaivani M; Vajpayee RB
Eye (Lond); 2009 Mar; 23(3):635-9. PubMed ID: 18292787
[TBL] [Abstract][Full Text] [Related]
20. The safety of nivolumab for the treatment of advanced non-small cell lung cancer.
Metro G; Ricciuti B; Brambilla M; Baglivo S; Soli I; Minenza E; Leonardi GC; D'arpino A; Colabrese D; Tazza M; Zicari D; Minotti V; Chiari R
Expert Opin Drug Saf; 2017 Jan; 16(1):101-109. PubMed ID: 27910704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]